Leadership
Board of Directors
The Physicians Network Board of Directors is composed of nine faculty members representative of the clinical divisions at M. D. Anderson. Each Director is appointed by the President of M. D. Anderson Cancer Center and serves a three year term. A Director may serve successive terms.
View our current Board of Directors (pdf)
The responsibilities of the Board of Directors include:
- Establish Physicians Network mission and vision statements and review them periodically to insure they fit well with the direction of the corporation
- Approve the strategic plan, which outlines strategies to grow the business of the organization, including the necessary resources
- Determine and approve the products and services to be offered that are consistent with the mission and vision
- Approve the annual operating budget and ensuring effective management of resources
- Build and maintain a strong public image by promoting the mission, vision and programs of the organization
- Recruit, train and evaluate board members and maintain a Board composition that is balanced and appropriate
- Ensure that the Physicians Network maintains ethical and legal practices to ensure accountability
Executive Leadership
Richard J. Babaian, MD
Professor
Senior Medical Director
Richard J. Babaian, MD, is Professor and Senior Medical Director. Prior to serving in this role, Dr. Babaian was Professor of Surgery in the Department of Urology, Director of the Prostate Detection Clinic and the Blanche Bender Professor in Cancer Research at the University of Texas M. D. Anderson Cancer Center.
Upon completion of his degree in medicine from Georgetown University, Dr. Babaian completed his internship at the University of Wisconsin and his residency at the University of Wisconsin and the University of North Carolina. Additionally, Dr. Babaian completed a three-year fellowship in Urologic Oncology.
Dr. Babaian practiced urologic oncology exclusively for over twenty years and has authored or co-authored more than 200 scientific publications the majority of which focus on prostate cancer and currently serves as a committee member on the NCCN Prostate Cancer Panel. He has a wide range of experience in the early detection, diagnosis, staging and management of prostate cancer and is experienced in the technique of cryosurgery and has utilized this modality in the treatment of prostate cancer both as primary therapy and as salvage following radiation therapy. His research interest focuses on prostate tumor markers and prediction models.
Miloslav Beran, M.D., Ph.D.
Professor
Medical Director
Miloslav Beran, MD, PhD, graduated from Karolinska Institute Medical School in Stockholm, Sweden with both M.D. and Ph.D. degrees. He completed his internship and residency training at Karolinska Hospital in Stockholm and M. D. Anderson Cancer Center fellowship program in Developmental Therapeutics from 1978-1980. After a short time as Assistant Professor of Medicine in charge of bone marrow transplantation for the Department of Hematology, Karolinska Hospital, Dr. Beran joined the staff of M. D. Anderson Cancer Center as Associate Professor and subsequently Professor of Medicine in the Department of Hematology/Leukemia, where he actively pursued both laboratory and clinical research until his retirement in 2008. Throughout his entire career, his commitments included preclinical laboratory research focused on the significance of leukemia biology for patient outcome, mechanisms of resistance to antileukemic agents and testing of new antileukemic drugs.
Dr. Beran combined these endeavors with direct patient care, development of new treatment strategies for treatment of leukemias and myelodysplastic syndromes and design and coordination of clinical trials. He published and lectured extensively and for his work received national and international recognition.
He continues collaboration with the staff of the Leukemia department.
Helmuth Goepfert, M.D.
Professor Emeritus
Medical Director
Helmuth Goepfert, MD, is Professor Emeritus and Medical Director. Prior to serving in this role, Dr. Goepfert was Department Chair of Head and Neck Surgery and Professor of Surgery. He was an administrative leader and practicing surgeon at M. D. Anderson Cancer Center for over thirty one years. His experience in clinical oncology and management of medical professionals is applied to his role in quality improvement process and concordance studies.
William A. Hyslop FACHE
President and Chief Executive Officer
Mr. Hyslop has over 30 years as a healthcare leader and has been with the M. D. Anderson Physicians Network since 1999. In his present capacity he has chief executive responsibilities for both the M. D. Anderson Physicians Network and the M. D. Anderson Services Corporation. Both corporations are subsidiary corporations to the M. D. Anderson Cancer Center and are involved in business relationships external to the M. D. Anderson Cancer Center. During Mr. Hyslop’s career, he has served as chief executive officer of three general acute care hospitals ranging in size from 250 beds to 400 beds and also as a regional CEO overseeing 7 not-for-profit community hospitals. He additionally organized and operated a national consulting firm that focused on healthcare merger and acquisitions, strategic business development and start-up company formations. He has worked in a diversity of settings that include for-profit and not-for-profit hospitals, independent hospitals and multi-hospital corporations as well as both public-general and academic organizations.
Brigid Pace
Vice President, Business Development
Ms. Pace is responsible for selecting Host Affiliates on behalf of M. D. Anderson Physicians Network. She participates in Executive Due Diligence with the prospect. This includes contractual responsibilities on behalf of the Host, contractual responsibilities on behalf of the physicians whom would participate in the affiliation, administrative budget, contract negotiation and executive oversight of the affiliation.
She has direct responsibility for working with the Host Affiliate to launch the marketing program. She coordinates all aspects of Clinical Due Diligence, which includes clinical presentations to the Host Affiliate physicians and coordinates Clinical Due Diligence, such as review of medical oncology clinical practices and radiation oncology site assessment.
In anticipation of an affiliation, she conducts market analysis in order to assess the potential success of an affiliation.
During the life of the program, she continues to maintain an Executive Liaison role with the affiliate.
William J. Simeone, Jr., MHA
Executive Director for Operations
Mr. Simeone has over twenty years experience as a healthcare leader at M. D. Anderson Cancer Center and has been the Executive Director for Operations since 2004.
In his role as Executive Director for Operations, he has responsibility for all M. D. Anderson Physicians Network clinical operations, which include account management, case management, credentialing, information systems, member services, provider relations, program development and quality improvement. Management oversight of these functions includes all processes related to support the Cancer Manager Host Affiliates, Employer and Clinical Support Services Agreements.
David G. Tubergen, M.D.
Medical Director
David G. Tubergen, MD, participates in program development and is responsible for the presentation of the Host program to the medical staff of potential participant institutions. This involves explaining the Host program content through direct interaction with the medical staff and its leadership and assessing the level of support and enthusiasm for the program. He participates in the review of the clinical due diligence process to ensure that the potential host has appropriate infrastructure, policies and procedures in place prior to beginning the Host relationship.